ストックスクリーナーアプリを入手
36.17
5.51%
-2.11
アフターアワーズ：
35.60
-0.57
-1.58%
Hims Hers Health Inc (HIMS) 最新ニュース
Technical Reactions to HIMS Trends in Macro Strategies - Stock Traders Daily
Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market - Yahoo Finance UK
Form 4 Hims Hers Health Inc For: 7 July By Investing.com - Investing.com Canada
Hims & Hers CFO Okupe sells $261k in stock By Investing.com - Investing.com Canada
Hims & Hers (NYSE: HIMS) CFO exercises options and sells 7,163 shares under 10b5-1 plan - Stock Titan
Hims & Hers Pullback Could Create a Better Entry Into GLP-1 Demand - Investing.com
HIMS Stock Hits 2026 High After Unlocking $400M Working Capital Through JPMorgan — Retail Gets Less Bearish - Stocktwits
Hims & Hers (HIMS) Stock May Be Undervalued After FDA Peptide Questions - Yahoo Finance
HIMS Stock Rises Overnight: CEO Shrugs Off Wild Swings, Bets On ‘Gold Standard’ Of Healthcare Over Next Decade - Stocktwits
Hims & Hers Health Inc (HIMS) Stock Up 4.0% and Still Undervalued -- GF Score: 81/100 - GuruFocus
Form 144 Hims & Hers Health For: 6 July By Investing.com - Investing.com Canada
[144] Hims & Hers Health, Inc. SEC Filing - Stock Titan
As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner - MarketBeat
HIMS Stock Slips Overnight After FDA Staff Questions Safety Of Popular Peptides — But One Analyst Says ‘This Isn’t The End’ - Stocktwits
Hims & Hers Health stock falls as insider files to sell shares - Investing.com
HIMS Breakout Signals Structural Business Transformation (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Inc at Morgan Stanley Technology, Media & Telecom Conference Transcript - GuruFocus
Hims & Hers Health Inc Stock Baskets | XSWX:HIMS - GuruFocus
Hims & Hers Health Inc (XSWX:HIMS) Stock News, Headlines & Updates - GuruFocus
Hims & Hers Health Inc (XSWX:HIMS) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Hims & Hers Health Inc (XSWX:HIMS) Stock Price & 30 Year Financial Data - GuruFocus
Hims & Hers Health Inc Stock Operating Data - GuruFocus
HIMS News | HIMS & HERS HEALTH INC (NYSE:HIMS) - ChartMill
Hims & Hers Health, Inc.: Target Price Consensus and Analysts Recommendations | HIMS | US4330001060 - marketscreener.com
HIMS Stock Jumps 8% as JPMorgan Facility and Analyst Upgrades Fuel Rally - FXLeaders
Hims & Hers Health Enters Receivables Purchase Agreement with JPMorgan Chase Bank – Key Terms and Details - Minichart
Hims & Hers Establishes New $400 Million Receivables Facility - TipRanks
Hims & Hers Launches $400 Million Receivables Facility, Amends Revolver to Support Program - TradingView
Hims & Hers (HIMS) adds $400M receivables facility and amends credit deal - Stock Titan
HIMS Stock Surges as Canaccord Genuity Raises Price Target - GuruFocus
Hims & Hers Stock Surges as Analysts Lift Price TargetsHims & Hers Health (NYSE:HIMS) - Benzinga
Hims & Hers stock jumps as Canaccord lifts target ahead of FDA review - TradingView
Hims & Hers Health (NYSE:HIMS) run trims Canaccord upside after GLP-1 reset - TechStock²
BofA raises Hims and Hers stock price target on FDA peptide review - Investing.com
Hims stock gains as FDA revives AdComs (HIMS:NYSE) - Seeking Alpha
HIMS Maintains by B of A Securities -- Price Target Raised to $3 - GuruFocus
HIMS Maintained by Canaccord Genuity -- Price Target Raised to $40 - GuruFocus
Why is Hims & Hers Health stock rallying today? By Investing.com - Investing.com Canada
Hims & Hers stock rises after Canaccord price target hike - Investing.com
Hims & Hers Health Price Target Raised to $40.00/Share From $32.00 by Canaccord Genuity - Moomoo
Hims & Hers Health, Inc. Stock 12‑Month Price Target Raised to $29.27, Implies 16% Downside - TradingView
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Canaccord raises Hims and Hers stock price target on weight loss drugs - Investing.com Canada
Hims & Hers Health Inc (HIMS) Shares Surge 3.8% -- What GF Score of 81 Tells Investors - GuruFocus
Hims & Hers Health, Inc. (HIMS) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
HIMS Stock On The Mend? New Testosterone Push Builds As GLP-1 Gold Rush Gets Crowded - Stocktwits
Lost Money on Hims & Hers Health, Inc. (HIMS)? Join Class Action Before August 25, 2025Contact Levi & Korsinsky - The National Law Review
Join Class Action to Recover Losses from Hims & Hers Health, Inc - The National Law Review
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Hims & Hers - The National Law Review
Hims & Hers Health Stock (HIMS) Opinions on Business Reacceleration and Analyst Upgrades - Quiver Quantitative
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Over Securities ViolationsContact Levi & Korsinsky Today - The National Law Review
Trading the Move, Not the Narrative: (HIMS) Edition - Stock Traders Daily
HIMS Stock Eyes Big Monthly Win: Novo Nordisk Calls Hims & Hers One Of Its Most ‘Voluminous’ Telehealth Partners - Stocktwits
OMCL or HIMS: Which Is the Better Value Stock Right Now? - Yahoo! Finance Canada
Hims & Hers Soars After Novo Nordisk Weight-Loss Nod - TipRanks
Hims & Hers: Can Fundamentals Really Support This Rebound Rally? (Downgrade) (NYSE:HIMS) - Seeking Alpha
Why is Hims & Hers Health stock up today? - Traders Union
Key facts: Hims sells GLP‑1s; 2.6M subs; Barclays $39, Leerink $25 - TradingView
Investor relations - HIMS Investor Relations
HIMS Stock | Hims & Hers Health, Inc. Price, Quote, News & Analysis - TipRanks
Hims & Hers Health slips as investors continue to weigh margin pressure and recent financing - Quiver Quantitative
Hims’ obesity drug business may get boost as employers drop coverage - WTVB
Analysis-Hims’ obesity drug business may get boost as employers drop coverage - WHTC
$Hims & Hers Health (HIMS.US)$ - Moomoo
Barclays Raises Price Target On Hims & Hers Health (NYSE: HIMS) As Weight Loss Business Drives Momentum - foreignpolicyjournal.com
Hims & Hers Health Options Spot-On: On June 24th, 62,597 Contracts Were Traded, With 937.02K Open Interest - Moomoo
CVS expands direct-to-consumer GLP-1 weight-loss program - The Business Journals
Is Hims & Hers Health, Inc. (HIMS) a Top Weight Loss Stock After Barclays’ Target Increase? - Insider Monkey
0.15%
1.95%
大文字化:
|
ボリューム (24 時間):